BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27070076)

  • 1. A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries.
    Mundal L; Retterstøl K
    Curr Opin Lipidol; 2016 Aug; 27(4):388-97. PubMed ID: 27070076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013.
    Mundal L; Igland J; Ose L; Holven KB; Veierød MB; Leren TP; Retterstøl K
    Eur J Prev Cardiol; 2017 Jan; 24(2):137-144. PubMed ID: 27794106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial hypercholesterolemia: experience from the French-Canadian population.
    Paquette M; Genest J; Baass A
    Curr Opin Lipidol; 2018 Apr; 29(2):59-64. PubMed ID: 29356704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of registries and genetic databases in familial hypercholesterolemia.
    Kindt I; Mata P; Knowles JW
    Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying familial hypercholesterolemia in acute coronary syndrome.
    Gencer B; Nanchen D
    Curr Opin Lipidol; 2016 Aug; 27(4):375-81. PubMed ID: 27092769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN
    Hormones (Athens); 2017 Jul; 16(3):306-312. PubMed ID: 30091117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry.
    Bamimore MA; Zaid A; Banerjee Y; Al-Sarraf A; Abifadel M; Seidah NG; Al-Waili K; Al-Rasadi K; Awan Z
    J Clin Lipidol; 2015; 9(2):187-94. PubMed ID: 25911074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature.
    Wong B; Kruse G; Kutikova L; Ray KK; Mata P; Bruckert E
    Clin Ther; 2016 Jul; 38(7):1696-709. PubMed ID: 27261205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN
    Hormones (Athens); 2017 Jul; 16(3):200-204. PubMed ID: 29278517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
    Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
    Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral arterial disease in heterozygous familial hypercholesterolemia.
    Pereira C; Miname MH; Makdisse MR; Watanabe C; Pesaro AE; Jannes CE; Kalil Filho R; Pereira AC; Santos RD
    Atherosclerosis; 2015 Sep; 242(1):174-8. PubMed ID: 26201001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting cardiovascular disease in familial hypercholesterolemia.
    Paquette M; Baass A
    Curr Opin Lipidol; 2018 Aug; 29(4):299-306. PubMed ID: 29708923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional and national familial hypercholesterolemia registries: present international application, importance, and needs for Canada.
    Al-Sarraf A; Allard M; Martinka M; Frohlich J
    Can J Cardiol; 2013 Jan; 29(1):6-9. PubMed ID: 22717249
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry.
    Alonso R; Díaz-Díaz JL; Arrieta F; Fuentes-Jiménez F; de Andrés R; Saenz P; Ariceta G; Vidal-Pardo JI; Almagro F; Argueso R; Prieto-Matos P; Miramontes JP; Pintó X; Rodriguez-Urrego J; Perez de Isla L; Mata P
    J Clin Lipidol; 2016; 10(4):953-961. PubMed ID: 27578128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all?
    Mata P; Alonso R; Pérez de Isla L
    Curr Opin Lipidol; 2018 Dec; 29(6):445-452. PubMed ID: 30382952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rationale and design of the national familial hypercholesterolemia registries in Turkey: A-HIT1 and A-HIT2 studies.
    Kayıkçıoğlu M; Tokgözoğlu L
    Turk Kardiyol Dern Ars; 2017 Apr; 45(3):261-267. PubMed ID: 28429694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
    Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
    J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
    Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
    Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction.
    Rerup SA; Bang LE; Mogensen UM; Engstrøm T; Jørgensen E; Pedersen F; Torp-Pedersen C; Gislason G; James S; Hagström E; Køber L; Fosbøl EL
    Am Heart J; 2016 Nov; 181():35-42. PubMed ID: 27823691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.